Russell Diez-Canseco - Sep 7, 2023 Form 4/A - Amendment Insider Report for Vital Farms, Inc. (VITL)

Role
President and CEO, Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
VITL
Transactions as of
Sep 7, 2023
Transactions value $
-$213,737
Form type
4/A - Amendment
Date filed
9/15/2023, 04:32 PM
Date Of Original Report
Sep 11, 2023
Previous filing
May 17, 2023
Next filing
Oct 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VITL Common Stock Options Exercise $89.3K +27.5K +13.59% $3.25 230K Sep 7, 2023 Direct F1, F2
transaction VITL Common Stock Sale -$303K -26.7K -11.14% $11.34 213K Sep 7, 2023 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VITL Employee Stock Option (right to buy) Options Exercise $0 -27.5K -29.04% $0.00 67.2K Sep 7, 2023 Common Stock 27.5K $3.25 Direct F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The exercise and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2023.
F2 The initial Form 4 filed on September 11, 2023, inadvertently omitted an additional 10,780 options that were exercised and held. This amendment lists the correct number of shares exercised and beneficially owned after each transaction.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.07 to $11.54 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Fully vested.